Twitter-Everyday Health deal means targeted Tweets

Share this article:
Twitter-Everyday Health deal means targeted Tweets
Twitter-Everyday Health deal means targeted Tweets

Should you, at the height of this fall's ragweed season in your neck of the woods, Tweet about how miserable your allergies are making you this fall, chances are a sponsored Tweet from Everyday Health will pop up in your feed, directing you to allergy information on their site.

Twitter is partnering with the health media firm on HealthBeat, through which sponsored posts (promoted Tweets, in Twitter argot) touting contextually relevant content will be routed to Twitter users, triggered by keyword, location or other algorithmic tripwires. Those promoted Tweets will bear breaking health news, seasonal issues like influenza and allergy info, and lifestyle tips.

“Twitter has become this global town square,” says Everyday Health's Jen Perciballi, “and this allows us to have conversations in real time.”

That means Everyday Health could target users Tweeting about coughing in South Central LA during an outbreak of Whooping Cough, as happened there in 2011, with Tweets linking to information on the condition.

“It has the capacity to be the first line of defense for public health,” said Perciballi. “It also provides marketers with an opportunity to scale up their targeted messaging,” she added. The platform can be customized to health topics or regions through promoted Tweets, sponsored Twitter search, video Tweets, branded communities, blogs, data, infographics, live Q&As and display ads on Everyday Health.

It's Twitter's only such partnership with a health media company.

“The combination of Twitter's data and reach with Everyday Health's depth of original content is a huge advancement in public health,” said Everyday Health's Dr. Sanjay Gupta in a statement. “Never before has health and wellness editorial been combined with the actual insights and data from the community at large, making this an invaluable resource for consumers and health professionals.”

Share this article:

Email Newsletters

More in News

House bill would speed approval once EU OKs same product

House bill would speed approval once EU OKs ...

The Speeding Access to Already Approved Pharmaceuticals Act of 2014 would require FDA to expedite the review of pharmaceuticals that are already approved by the European Union

Rep access continues to shrink

Rep access continues to shrink

Sales reps are experiencing even more limited physician access, according to a report by Chicago consultancy ZS Associates.

Allergan touts reorg, plans to lay off 13% of workforce

Allergan touts reorg, plans to lay off 13% ...

Allergan's second-quarter earnings, and a new round of cuts, are now part of the Botox maker's record as it seeks to remain independent.